654 related articles for article (PubMed ID: 22248874)
21. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
[TBL] [Abstract][Full Text] [Related]
22. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
[TBL] [Abstract][Full Text] [Related]
26. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis.
Livestro DP; Kaine EM; Michaelson JS; Mihm MC; Haluska FG; Muzikansky A; Sober AJ; Tanabe KK
Cancer; 2007 Aug; 110(3):614-24. PubMed ID: 17577228
[TBL] [Abstract][Full Text] [Related]
27. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
28. Biology of desmoplastic melanoma: a case-control comparison with other melanomas.
Livestro DP; Muzikansky A; Kaine EM; Flotte TJ; Sober AJ; Mihm MC; Michaelson JS; Cosimi AB; Tanabe KK
J Clin Oncol; 2005 Sep; 23(27):6739-46. PubMed ID: 16170181
[TBL] [Abstract][Full Text] [Related]
29. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
[TBL] [Abstract][Full Text] [Related]
30. Sarcopenia as a prognostic factor among patients with stage III melanoma.
Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
[TBL] [Abstract][Full Text] [Related]
31. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
32. Skin metastases of malignant melanoma: a clinical and prognostic survey.
Savoia P; Fava P; Nardò T; Osella-Abate S; Quaglino P; Bernengo MG
Melanoma Res; 2009 Oct; 19(5):321-6. PubMed ID: 19641475
[TBL] [Abstract][Full Text] [Related]
33. In-transit intramammary sentinel lymph nodes from malignant melanoma of the trunk.
Lyo V; Jaigirdar AA; Thummala S; Morita ET; Treseler PA; Kashani-Sabet M; Leong SP
Ann Surg; 2012 Jan; 255(1):122-7. PubMed ID: 22143205
[TBL] [Abstract][Full Text] [Related]
34. Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials.
Joosse A; Collette S; Suciu S; Nijsten T; Lejeune F; Kleeberg UR; Coebergh JW; Eggermont AM; de Vries E
J Clin Oncol; 2012 Jun; 30(18):2240-7. PubMed ID: 22547594
[TBL] [Abstract][Full Text] [Related]
35. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
[TBL] [Abstract][Full Text] [Related]
36. [The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage].
Ługowska I; Kowalska M; Zdzienicki M; Fuksiewicz M; Kamińska J; Szamotulska K; Rutkowski P
Pol Merkur Lekarski; 2012 Jan; 32(187):22-7. PubMed ID: 22400175
[TBL] [Abstract][Full Text] [Related]
37. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases.
Bron LP; Traynor SJ; McNeil EB; O'Brien CJ
Laryngoscope; 2003 Jun; 113(6):1070-5. PubMed ID: 12782825
[TBL] [Abstract][Full Text] [Related]
38. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
[TBL] [Abstract][Full Text] [Related]
39. Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study.
Kim HS; Kim EK; Jun HJ; Oh SY; Park KW; Lim DH; Lee SI; Kim JH; Kim KM; Lee DH; Lee J
BMC Cancer; 2010 Apr; 10():167. PubMed ID: 20426858
[TBL] [Abstract][Full Text] [Related]
40. Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
Lee CC; Faries MB; Wanek LA; Morton DL
J Clin Oncol; 2008 Feb; 26(4):535-41. PubMed ID: 18235114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]